Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 1;31(4):369-376.
doi: 10.1097/CEJ.0000000000000711. Epub 2021 Sep 13.

Strategies for Lynch syndrome identification in selected and unselected gynecological cancers

Affiliations

Strategies for Lynch syndrome identification in selected and unselected gynecological cancers

Ileana Carnevali et al. Eur J Cancer Prev. .

Abstract

Background: Endometrial carcinoma represents a sentinel cancer for Lynch syndrome (LS) identification. It is crucial to highlight how other types of tumors can arise in the gynecological tract acting as sentinel tumors in LS patients.Up to now, no established LS patient management strategy has incorporated the presence of these additional candidate sentinel tumors to improve the prevention and management of LS tumors.

Methods: In order to investigate the involvement of the most frequent gynecological cancers in gynecological cancers, we studied different subsets of gynecological cancers using both somatic approaches, including mismatch repair (MMR) gene immunohistochemical expression, microsatellite instability, and germline analyses ofMSH2, MSH6, MLH1, PMS2 and EPCAM genes.A total of 261 patients referring to the Cancer Genetic Counselling Service of our institution were included in the study. In detail, our series was composed of 131 patients affected by uterus cancers including endometrial, isthmus and non-HPV endocervical carcinomas, 113 patients affected by ovarian cancers and 17 patients affected by synchronous endometrial/ovarian carcinomas (SEOC).In addition, we studied 115 cases of endometrial cancers identified by 2 years of universal testing (endometrial cancers/UTs) using IHC analysis of four MMR proteins.

Results and conclusions: The incidence of MMR defective gynecological cancers ranged from 7.1 to 47.1% depending on cancer site and selection. LS patients carriers of pathogenetic MMR variants were identified in 19.8% of uterus cancers, 35.3% of SEOC, 4.4% of ovarian cancers. In addition, pathogenetic MMR variants were identified in 4.3% of endometrial cancers/universal testing investigated with universal screening.In conclusion, gynecological cancers are heavily involved in LS and our study shows that MMR screening using immunohistochemical pattern and MSI analysis of endometrial and ovarian cancers as well as of rare entities such as non-HPV related endocervical cancers and synchronous endometrial and ovarian cancers are sentinels for LS.Tumor testing approach improves early identification of MMR defective gynecological cancers and this is an effective strategy to detect high-risk patients and to offer them and their relatives personalized cancer prevention.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bartosch C, Clarke B, Bosse T. (2018). Gynaecological neoplasms in common familial syndromes (Lynch and HBOC). Pathology 50:222–237.
    1. Burn J, Sheth H, Elliott F, Reed L, Macrae F, Mecklin JP, et al.; CAPP2 Investigators. (2020). Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial. Lancet 395:1855–1863.
    1. Chiaravalli AM, Carnevali I, Sahnane N, Leoni E, Furlan D, Berselli M, et al. (2020). Universal screening to identify Lynch syndrome: two years of experience in a Northern Italian Center. Eur J Cancer Prev 29:281–288.
    1. Cini G, Carnevali I, Sahnane N, Chiaravalli AM, Dell’Elice A, Maestro R, et al. (2021). Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3’UTR of the MSH6 gene. Cancer Genet 254–255:1–10.
    1. Cini G, Carnevali I, Quaia M, Chiaravalli AM, Sala P, Giacomini E, et al. (2015). Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family. Carcinogenesis 36:452–458.

MeSH terms